查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1754184

人工生命器官和醫療仿生市場報告（按產品類型（人工生命器官、醫療仿生學）、應用（醫院、診所等）和地區）2025 年至 2033 年

Artificial Vital Organs and Medical Bionics Market Report by Product Type (Artificial Vital Organs, Medical Bionics), Application (Hospitals, Clinics, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球人工重要器官和醫療仿生市場規模達492億美元。展望未來， IMARC Group預計到2033年，市場規模將達到745億美元，2025-2033年期間的複合年成長率（CAGR）為4.48%。呼吸系統疾病、肝硬化、心臟和肝衰竭盛行率的上升，易患器官疾病的老年人口的增加，以及各種技術進步，是推動市場發展的一些關鍵因素。

人工重要器官，通常被稱為人造器官或生物人工器官，是旨在模擬人體自然器官功能的人造裝置。這些裝置旨在臨時或永久取代功能失常或衰竭的生物器官，幫助患者維持基本身體功能，在某些情況下甚至增強其功能。另一方面，醫學仿生學是醫學科學與工程的一個領域，專注於開發和整合生物和人工組件，以恢復或增強人體功能。

目前，各種疾病的發生率顯著上升，包括呼吸系統疾病、肝硬化以及心臟、腎臟和肝衰竭。這種激增與醫療保健產業的擴張密切相關，並成為市場成長的重要催化劑。此外，全球範圍內老年人口的不斷成長，尤其容易患上器官相關疾病，這也對市場擴張做出了重大貢獻。此外，功能齊全的人工心臟、肝臟、肺、尿道、氣管和腎臟等創新產品的不斷發展，正在對市場動態產生積極的影響。此外，主要的市場參與者正在大力投資研發 (R&D) 工作，旨在引入透過工程組織進行器官再生的尖端方法。這種持續的創新正在為市場培育光明的前景。此外，隨著生物人工器官的出現，對人工器官的需求也不斷成長，這些器官可以提高存活率並加快患者康復速度。這種不斷成長的需求因移植橋樑和危重醫療病例復健橋樑等救生技術的實施而進一步推動，進一步促進了市場成長。

人工生命器官與醫療仿生市場趨勢/促進因素：

呼吸系統疾病、肝硬化和器官衰竭盛行率上升

慢性阻塞性肺病 (COPD) 和肺部感染等呼吸系統疾病的發生率顯著上升。患有嚴重呼吸系統疾病的患者通常需要人工肺部或其他輔助設備才能充分呼吸。此外，由於過量飲酒、病毒性肝炎感染和非酒精性脂肪肝等各種因素，包括肝硬化在內的肝病發生率也呈現上升趨勢。晚期肝硬化患者可能需要肝臟移植，而人工肝臟可以作為肝臟移植的過渡治療，甚至是長期解決方案。此外，心臟和肝衰竭是全球範圍內的重大健康問題。由於人口老化、肥胖和生活方式選擇等因素，充血性心臟衰竭和末期肝病等疾病的發生率正在上升。人工心臟和肝臟支持系統在患者等待移植期間或作為永久性支持方案時，在提供挽救生命的解決方案方面發揮著至關重要的作用。

全球老年人口不斷增加

全球人口結構正朝向老化轉變。由於自然老化過程，老年人更容易患上器官疾病，因此他們成為人工重要器官干預的關鍵人群。此外，老年人更容易罹患慢性疾病，包括心血管疾病、呼吸系統疾病和腎臟疾病。這些疾病通常需要人工心臟、人工肺或人工腎臟等干涉措施來管理或改善患者的生活品質。心律調節器和人工耳蝸等醫療仿生技術也常用於老年人，以解決與年齡相關的健康問題。人工重要器官和醫療仿生技術對於延長和改善老年人的壽命至關重要，使他們能夠在晚年享受更高品質的生活。

各種技術進步

醫療技術的進步顯著提升了人工重要器官和醫學仿生學的設計、功能和有效性。此外，功能齊全的人工器官（例如人工心臟和人工肺）也得到了開發，其功能得到了增強，使患者能夠過上更積極的生活。此外，尖端材料與生物工程技術的融合，催生了與自然器官高度相似的生物人工器官，從而降低了排斥風險並改善了患者的整體治療效果。此外，醫療科技產業的領導者正在大力投資旨在改善人工重要器官和醫學仿生學的研發活動。這些投資促進了更精密的設備、更先進的材料和更先進的手術技術的開發，所有這些都有助於改善患者的治療效果。

本報告回答的關鍵問題

  • 人工生命器官和醫療仿生市場有多大？ 2025-2033年全球人工生命器官和醫療仿生市場的預期成長率是多少？
  • 推動全球人工生命器官和醫療仿生市場發展的關鍵因素有哪些？
  • COVID-19 對全球人工生命器官和醫療仿生市場有何影響？
  • 根據產品類型，全球人工生命器官和醫療仿生市場是如何分佈的？
  • 全球人工生命器官和醫療仿生學市場的重點區域有哪些？
  • 全球人工生命器官和醫療仿生學市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球人工生命器官與醫療仿生市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 人工重要器官
    • 關鍵部分
      • 人工肝臟
      • 人工心臟
      • 人工胰臟
      • 人工腎臟
      • 人工肺
      • 氧合器
  • 醫療仿生學
    • 關鍵部分
      • 仿生肢體
      • 視覺仿生學
      • 耳仿生學
      • 外骨骼
      • 腦仿生學
      • 心臟瓣膜
      • 心臟仿生學

第7章：市場區隔：依應用

  • 醫院
  • 診所
  • 其他

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第9章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abiomed
    • BiVACOR Inc
    • CARMAT
    • Cirtec Medical
    • Edwards Lifesciences
    • Ekso Bionics Holdings Inc.
    • Nikkiso Co. Ltd.
    • Second Sight Medical Products Inc
    • SynCardia Systems LLC (Picard Medical Inc.)
Product Code: SR112025A6458

The global artificial vital organs and medical bionics market size reached USD 49.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 74.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.48% during 2025-2033. The rising prevalence of respiratory ailments, cirrhosis, and heart and liver failures, the increasing geriatric population that is highly prone to organ disorders, and various technological advancements represent some of the key factors driving the market.

Artificial vital organs, often referred to as artificial organs or bioartificial organs, are man-made devices designed to mimic the functions of natural organs within the human body. These devices are developed to serve as temporary or permanent replacements for malfunctioning or failed biological organs, helping patients maintain essential bodily functions and, in some cases, even enhancing them. On the other hand, medical bionics is a field of medical science and engineering that focuses on the development and integration of biological and artificial components to restore or enhance the functioning of the human body.

Currently, there is a notable surge in the prevalence of various medical conditions, including respiratory disorders, cirrhosis, as well as heart, kidney, and liver failures. This surge is closely tied to the expanding healthcare sector and serves as a significant catalyst for market growth. Furthermore, the increasing elderly population, which is particularly susceptible to organ-related ailments worldwide, is making a substantial contribution to the market's expansion. Moreover, the continuous development of innovative products, such as fully functional artificial hearts, livers, lungs, urethras, windpipes, and kidneys, is exerting a positive impact on market dynamics. Additionally, major market players are making substantial investments in research and development (R&D) endeavors, aimed at introducing cutting-edge methods of organ regeneration through engineered tissues. This ongoing innovation is fostering a promising outlook for the market. Besides this, there is a rising demand for artificial organs, driven by the emergence of bioartificial organs that offer improved survival rates and faster patient recovery. This growing demand is further propelled by the implementation of life-saving technologies like the bridge to transplant and the bridge to recovery in critical medical cases, further reinforcing market growth.

Artificial Vital Organs and Medical Bionics Market Trends/Drivers:

Rising prevalence of respiratory ailments, cirrhosis, and organ failures

There has been a notable increase in the prevalence of respiratory ailments such as chronic obstructive pulmonary disease (COPD) and lung infections. Patients with severe respiratory issues often require artificial lungs or other assistive devices to breathe adequately. Moreover, liver diseases, including cirrhosis, have seen a rise due to various factors like excessive alcohol consumption, viral hepatitis infections, and non-alcoholic fatty liver disease. In advanced stages, cirrhosis may necessitate liver transplantation, and artificial livers can serve as a bridge to transplantation or even a long-term solution. Besides, heart and liver failures are significant health concerns worldwide. Conditions like congestive heart failure and end-stage liver disease are on the rise due to factors such as an aging population, obesity, and lifestyle choices. Artificial hearts and liver support systems play a crucial role in providing life-saving solutions while patients await transplantation or as a permanent support option.

Increasing geriatric population across the globe

The global demographic landscape is shifting toward an aging population. Elderly individuals are more susceptible to organ disorders due to the natural aging process, making them a key demographic for artificial vital organ interventions. Besides, the elderly population is more prone to chronic medical conditions, including cardiovascular diseases, respiratory ailments, and kidney disorders. These conditions frequently require interventions such as artificial hearts, lungs, or kidneys to manage or improve the patient's quality of life. Medical bionics, such as pacemakers and cochlear implants, are also commonly used in elderly individuals to address age-related health issues. Artificial vital organs and medical bionics become crucial in extending and improving the lives of these elderly individuals, allowing them to enjoy a better quality of life in their later years.

Various technological advancements

Advancements in medical technology have significantly improved the design, functionality, and effectiveness of artificial vital organs and medical bionics. Moreover, full-functioning artificial organs, such as artificial hearts and lungs, have been developed with enhanced capabilities, allowing patients to lead more active lives. Besides, the integration of cutting-edge materials and bioengineering techniques has led to the creation of bioartificial organs that closely mimic natural organs, reducing the risk of rejection and improving overall patient outcomes. Additionally, leading players in the medical technology industry are investing heavily in research and development activities aimed at improving artificial vital organs and medical bionics. These investments result in the development of more sophisticated devices, enhanced materials, and improved surgical techniques, all of which contribute to better patient outcomes.

Key Market Segmentation:

Breakup by Product Type:

  • Artificial Vital Organs
    • Artificial Liver
    • Artificial Heart
    • Artificial Pancreas
    • Artificial Kidney
    • Artificial Lungs
    • Oxygenators
  • Medical Bionics
    • Bionic Limbs
    • Vision Bionics
    • Ear Bionics
    • Exoskeletons
    • Brain Bionics
    • Heart Valves
    • Cardiac Bionics

Artificial vital organs represent the most used product type

Artificial vital organs are designed to mimic the functions of natural vital organs such as the heart, lungs, kidneys, and liver. These devices are often used as a last resort when a patient's natural organs fail. They serve a life-saving function, providing crucial support to sustain a patient's life until a transplant becomes available or the natural organs recover. Moreover, there is a consistently high demand for artificial vital organs due of the prevalence of organ failure and the limited availability of organ donors. Individuals worldwide suffer from conditions that can lead to organ failure, and the demand for replacement organs far exceeds the supply. Artificial vital organs bridge this gap by offering a viable solution to patients in critical need.

Breakup by Application:

  • Hospitals
  • Clinics
  • Others

Hospitals are a primary application for artificial vital organs and medical bionics. In these healthcare facilities, artificial vital organs such as artificial hearts, lungs, and kidneys are often used to support patients with organ failure while they await transplants. Additionally, medical bionics, including devices like cochlear implants and bionic limbs, may be provided to patients in hospital settings to improve their quality of life and functional capabilities.

Clinics, including specialized medical centers and outpatient facilities, play a crucial role in the application of artificial vital organs and medical bionics. These settings are where patients may receive diagnosis, consultation, and follow-up care related to these advanced medical technologies. Clinics often offer services related to the assessment, fitting, and maintenance of medical bionics, making them essential in the continuum of care.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America, particularly the United States and Canada, boasts a highly advanced healthcare infrastructure with state-of-the-art medical facilities and research institutions. This infrastructure fosters innovation and the development of cutting-edge medical technologies, including artificial vital organs and medical bionics. Besides, the region is a global hub for medical research and development. Leading universities, medical centers, and private companies collaborate to push the boundaries of medical science. This collaborative environment accelerates the creation and commercialization of medical bionics and artificial vital organs. Moreover, the region has well-established regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and Health Canada, which ensure the safety and efficacy of medical devices. A robust regulatory framework provides confidence to investors, manufacturers, and healthcare providers, encouraging the development and adoption of medical bionics.

Competitive Landscape:

The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are heavily investing in R&D to develop innovative and advanced artificial vital organs and medical bionics. They focus on improving the performance, durability, and safety of these devices, as well as reducing their size and enhancing compatibility with the human body. They are also expanding their product portfolios to cover a broader range of medical bionics and artificial organs. This diversification allows them to address a wider array of medical conditions and patient needs. Besides, companies are acquiring or merging with other companies in the industry to expand capabilities, gain access to new technologies, and increase market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abiomed
  • BiVACOR Inc
  • CARMAT
  • Cirtec Medical
  • Edwards Lifesciences
  • Ekso Bionics Holdings Inc.
  • Nikkiso Co. Ltd.
  • Second Sight Medical Products Inc
  • SynCardia Systems LLC (Picard Medical Inc.)

Key Questions Answered in This Report

  • 1.How big is the artificial vital organs and medical bionics market?
  • 2.What is the expected growth rate of the global artificial vital organs and medical bionics market during 2025-2033?
  • 3.What are the key factors driving the global artificial vital organs and medical bionics market?
  • 4.What has been the impact of COVID-19 on the global artificial vital organs and medical bionics market?
  • 5.What is the breakup of the global artificial vital organs and medical bionics market based on the product type?
  • 6.What are the key regions in the global artificial vital organs and medical bionics market?
  • 7.Who are the key players/companies in the global artificial vital organs and medical bionics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Vital Organs and Medical Bionics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Artificial Vital Organs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Artificial Liver
      • 6.1.2.2 Artificial Heart
      • 6.1.2.3 Artificial Pancreas
      • 6.1.2.4 Artificial Kidney
      • 6.1.2.5 Artificial Lungs
      • 6.1.2.6 Oxygenators
    • 6.1.3 Market Forecast
  • 6.2 Medical Bionics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bionic Limbs
      • 6.2.2.2 Vision Bionics
      • 6.2.2.3 Ear Bionics
      • 6.2.2.4 Exoskeletons
      • 6.2.2.5 Brain Bionics
      • 6.2.2.6 Heart Valves
      • 6.2.2.7 Cardiac Bionics
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abiomed
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BiVACOR Inc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 CARMAT
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cirtec Medical
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Ekso Bionics Holdings Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Nikkiso Co. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Second Sight Medical Products Inc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 SynCardia Systems LLC (Picard Medical Inc.)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Artificial Vital Organs and Medical Bionics Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: North America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: North America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: United States: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: United States: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Canada: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Canada: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: China: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: China: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Japan: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Japan: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: India: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: India: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: South Korea: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: South Korea: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Australia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Australia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Indonesia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Indonesia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Europe: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Europe: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Germany: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Germany: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: France: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: France: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United Kingdom: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United Kingdom: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Italy: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Italy: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Spain: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Spain: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Russia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Russia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Latin America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Latin America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Brazil: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Brazil: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Mexico: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Mexico: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Breakup by Country (in %), 2024
  • Figure 65: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Global: Artificial Vital Organs and Medical Bionics Industry: SWOT Analysis
  • Figure 67: Global: Artificial Vital Organs and Medical Bionics Industry: Value Chain Analysis
  • Figure 68: Global: Artificial Vital Organs and Medical Bionics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Vital Organs and Medical Bionics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Artificial Vital Organs and Medical Bionics Market: Competitive Structure
  • Table 6: Global: Artificial Vital Organs and Medical Bionics Market: Key Players